Thrombotic thrombocytopenic purpura surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Thrombotic thrombocytopenic purpura medical therapy}}
 
{{CMG}}; {{AE}}  {{S.G.}}
{{CMG}}; {{AE}}  {{S.G.}}


==Overview==
==Overview==
The mainstay of treatment for TTP is medical therapy. Surgery is usually reserved for patients with either no cure with plasma treatments and medicines.
The mainstay of treatment for TTP is [[medical]] [[therapy]]. [[Surgery]] is usually reserved for [[Patient|patients]] with either no [[cure]] with [[plasma]] [[Treatment|treatments]] and medicines.


==Indications==
==Indications==
*Surgery is not the first-line treatment option for patients withTTP when plasma treatments and medicines do not cure TTP, surgury is needed.<ref name="pmid11604563">{{cite journal |vauthors=Medina PJ, Sipols JM, George JN |title=Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome |journal=Curr. Opin. Hematol. |volume=8 |issue=5 |pages=286–93 |date=September 2001 |pmid=11604563 |doi= |url=}}</ref>
*[[Surgery]] is not the [[First-line treatment|first line treatment]] option for [[Patient|patients]] withTTP when [[plasma]] treatments(PEX) and medicines do not [[cure]] TTP, [[surgery]] is needed.<ref name="pmid11604563">{{cite journal |vauthors=Medina PJ, Sipols JM, George JN |title=Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome |journal=Curr. Opin. Hematol. |volume=8 |issue=5 |pages=286–93 |date=September 2001 |pmid=11604563 |doi= |url=}}</ref>


==Surgery==
==Surgery==
*Surgery is not the first-line treatment option for patients withTTP. Sometimes spelenectomy is needed, because the antibodies is made by cell in spleen that block ADAMTS13 enzyme activity.
*[[Surgery]] is not the [[first-line treatment]] option for [[Patient|patients]] withTTP. Sometimes [[splenectomy]] is needed, because the [[antibodies]] is made by [[Cell (biology)|cell]] in [[spleen]] that block [[ADAMTS13]] [[enzyme]] [[Activity (chemistry)|activity]].<ref name="pmid11604563" />
 
==Contraindications==


==References==
==References==

Revision as of 16:31, 5 October 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

The mainstay of treatment for TTP is medical therapy. Surgery is usually reserved for patients with either no cure with plasma treatments and medicines.

Indications

Surgery

References

  1. 1.0 1.1 Medina PJ, Sipols JM, George JN (September 2001). "Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome". Curr. Opin. Hematol. 8 (5): 286–93. PMID 11604563.

Template:WH Template:WS